Health

COVID-19 Vaccine Maker Starts Working on Shots, Health News, ET Health World for Omicron

BioNTech, Moderna, Johnson & Johnson are working on vaccines specifically targeting Omicron in case existing shots are ineffective against new coronavirus variants, the two companies said Monday.

The emergence of this variant has sparked a strong global response, as countries are concerned that vaccinated populations may also spread rapidly.

BioNTech SE said it has begun developing a vaccine tailored to Omicron with partner Pfizer.

Meanwhile, Moderna Inc could take months to begin shipping such vaccines, CEO Stephane Bancel told CNBC.

Bansel added that the efficacy of the existing COVID-19 vaccine against the mutant is currently unknown and should become clearer in about two weeks.

While Johnson & Johnson are also assessing the efficacy of the COVID-19 vaccine against Omicron, they are also pursuing vaccines that are specific to that variant.

Matthew Mamen, Head of Global Research at J & J’s Pharmaceuticals Division, said:

Top South African infectious disease experts said Omicron appears to be more contagious than previous variants, including people with immunity from vaccination and previous infections.

(Report by Manas Mishra in Bangalore; edited by Sriraj Kalluvila)



COVID-19 Vaccine Maker Starts Working on Shots, Health News, ET Health World for Omicron

Source link COVID-19 Vaccine Maker Starts Working on Shots, Health News, ET Health World for Omicron

Related Articles

Back to top button